Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02927301
Brief Title: A Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Resectable Non-Small Cell Lung Cancer (NSCLC) - Lung Cancer Mutation Consortium (LCMC3)

First Submitted : October 5, 2016
First Submitted that Met QC Criteria : October 5, 2016
First Posted : October 7, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 13, 2019
Last Update Posted : May 14, 2019